Evidence map›Paper›PMID 38580539›Full record

ReviewHuman immunology2024

Tolerance in intestinal transplantation.

Megan Sykes

Abstract readReview
In one paragraph

Review in Human immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Department of Microbiology and Immunology and Department of Surgery, Columbia University, New York, NY, USA. Electronic address: ms3976@cumc.columbia.edu.

Funding

Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
STATISTICAL COREP01CA111519 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FINKELSTEIN, DIANNE M · 2006 to 2010
$9.3M
SEPARATION OF GVH AND GVL IN MOUSE MODELSR01CA079989 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 2000 to 2008
$2.2M
Mechanisms of tolerance in recipients of combined kidney and bone marrow transplaR01AI084074 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 2009 to 2010
$862k
NCI NIH HHS P01 CA111519NCI NIH HHS R01 CA079989NIAID NIH HHS P01 AI106697NIAID NIH HHS R01 AI084074
6 · The paper itself

Abstract

Intestinal transplantation (ITx) is highly immunogenic, resulting in the need for high levels of immunosuppression, with frequent complications along with high rejection rates. Tolerance induction would provide a solution to these limitations. Detailed studies of alloreactive T cell clones as well as multiparameter flow cytometry in the graft and peripheral tissues have provided evidence for several tolerance mechanisms that occur spontaneously following ITx, which might provide targets for further interventions. These include the frequent occurrence of macrochimerism and engraftment in the recipient bone marrow of donor hematopoietic stem and progenitor cells carried in the allograft. These phenomena are seen most frequently in recipients of multivisceral transplants and are associated with reduced rejection rates. They reflect powerful graft-vs-host responses that enter the peripheral lymphoid system and bone marrow after expanding within and emigrating from the allograft. Several mechanisms of tolerance that may result from this lymphohematopoietic graft-vs-host response are discussed. Transcriptional profiling in quiescent allografts reveals tolerization of pre-existing host-vs-graft-reactive T cells that enter the allograft mucosa and become tissue-resident memory cells. Dissection of the pathways driving and maintaining this tolerant tissue-resident state among donor-reactive T cells will allow controlled tolerance induction through specific therapeutic approaches.

Indexed as

Graft RejectionIntestinesTransplantation ToleranceAnimalsGraft vs Host ReactionHumansImmune ToleranceOrgan TransplantationT-LymphocytesTransplantation, HomologousGraft-vs-host responseIntestinal transplantationSingle cell transcriptomicsT cellsTolerance

Identifiers

PMID38580539
PMCPMC11144570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.